4 Ways Technology Can Optimize Clinical Trial Workflows

In 2003, the cost to fully develop an FDA approved drug was $803 million1. Now, however, that price has skyrocketed up to 2.6 billion and there have been no signs of this rate slowing down!

Unfortunately, while the price to develop drugs have increased, the rate of clinical trial success has decreased by about 12% in this span.

Therefore, this results in ever-increasing pressure to increase efficiency and reduce costs of clinical trials, which can be a major catch-22.